Navigation Links
NutraCea to Host Third Quarter 2007 Financial Results Conference Call November 14

PHOENIX, Nov. 9 /PRNewswire-FirstCall/ -- NutraCea (OTC Bulletin Board: NTRZ), a health science company and a world leader in stabilized rice bran (SRB), announced today that it will release its third quarter financial results on Wednesday, November 14 after the market closes.

Management will host the conference call on November 14 at 5:30 PM EST to review NutraCea's 2007 third quarter financial results and provide management updates. Parties interested in listening to the conference call should call 800-240-8926. International callers should dial 303-262-2143. The call is also available via a webcast that can be accessed at and will be archived for 30 days.

About NutraCea

NutraCea is a leader in stabilized rice bran nutrient research and dietary supplement development. Through its wholly-owned subsidiary, RiceX, the Company manufactures (as well as distributes) products and food ingredients made from Rice Bran through its proprietary technology and processes. The Company has developed intellectual properties to create a range of proprietary product formulations, delivery systems and whole-food nutrition products. NutraCea's proprietary technology enables the creation of food and nutrition products from rice bran, normally a wasted by-product of standard rice- processing. In addition to its whole-foods products, NutraCea develops families of health- promoting "nutraceuticals," including natural arthritic relief and cholesterol-lowering products. More information can be found in the Company's filings with the SEC, and you can visit the NutraCea Web site

Company Contact:

Margie Adelman

Senior V.P. NutraCea


916-220-3500 cell

Investor Relations Contact:

Marilynn Meek

Financial Relations Board


Julie Tu

Financial Relations Board


Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. NutraCea Appoints Financial Relations Board as New Investor Relations Firm
2. More than two-thirds of sexually active NYC youth use condoms, but other forms of birth control lag
3. Haemacure Reports Third Quarter 2007 Results
4. Burgeoning Population of Hepatitis C Virus Patients in Need of Second- and Third-Line Treatment Options
5. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
6. Martek Announces Third Quarter 2007 Financial Results
7. MDS Reports Third Quarter 2007 Results
8. Plexus Systems Ranks in Top Third of the 2007 Inc. 5,000 with Three-Year Sales Growth of 226%
9. Michael Moores SiCKO Becomes the Third Highest Grossing Documentary of All Time Surpassing An Inconvenient Truth
10. Webcast Alert: Heska Announces Third Quarter 2007 Earnings Conference Call Webcast
11. AABB and Fenwal Sponsor Third Annual Blood Collectors Week
Post Your Comments:
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: